Picterus is making remarkable strides in the field of neonatal jaundice (NNJ) screening and monitoring.
Building on their mobile app financed under the SME Instrument, Picterus now aims to equip parents with a fast, affordable, and reliable digital platform for detecting and managing neonatal jaundice in newborns at home.
Neonatal jaundice affects a staggering 60% to 80% of newborns worldwide, with severe jaundice potentially leading to brain damage or even death in 10% of cases. By harnessing the power of smartphones and utilizing Picterus’s recommendation tool, families can monitor NNJ levels in newborns conveniently and efficiently. This not only empowers families to take an active role in their child’s health but also reduces the strain on healthcare systems by minimizing unnecessary visits.
For its breakthrough solution that will ultimately save countless lives and prevent long-term neurological impairments, Picterus achieved the support of the EIC Accelerator programme.
